Spravato®

Company
Janssen Therapeutics
Use
Treatment-resistant depression
Features
Esketamine nasal spray used with oral antidepressant.
NIH Contribution
Research on treatment-resistant intranasal ketamine for depression.
Success Stories
https://www.techtransfer.nih.gov/news/julys-featured-product-first-fda-approved-prescription-nasal-spray-for-treatment-resistant
HHS Institute/Agency
NIMH
Inventor(s)
Manji, H. et al.
Year
2019

 

Return to Product Showcase

Request More Info

Spravato nasal spray